Clinical Trial Update: Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing efficacy and safety of Divaza for cerebral atherosclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Atherosclerosis

Drugs mentioned

• Divaza

Snippet

Sponsor: Materia Medica Holding | Conditions: Cerebral Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2021-08-26